Refine your search:     
Report No.

Successful labeling of $$^{rm 99m}$$Tc-MDP using $$^{rm 99m}$$Tc separated from $$^{99}$$Mo produced by $$^{100}$$Mo($textit{n}$,2$textit{n}$)$$^{99}$$Mo

Nagai, Yasuki; Hatsukawa, Yuichi; Kin, Tadahiro; Hashimoto, Kazuyuki; Motoishi, Shoji; Konno, Chikara; Ochiai, Kentaro; Takakura, Kosuke; Sato, Yuichi*; Kawauchi, Yukimasa*; Sato, Norihito*; Ota, Akio*; Yamabayashi, Hisamichi*; Tanase, Masakazu*; Fujisaki, Saburo*; Teranaka, Tomoyuki*; Takeuchi, Nobuhiro*; Igarashi, Takashi*

We have for the first time succeeded to separate $$^{rm 99m}$$Tc from a Mo oxide sample irradiated by accelerator neutrons, and to formulate $$^{rm 99m}$$Tc-methylene diphosphonate ($$^{rm 99m}$$Tc-MDP). $$^{99}$$Mo, the mother nuclide of $$^{rm 99m}$$Tc, was produced by the $$^{100}$$Mo($textit{n}$,2$textit{n}$)$$^{99}$$Mo reaction using about 14 MeV neutrons provided at the Fusion Neutronics Source of Japan Atomic Energy Agency. The $$^{rm 99m}$$Tc was separated from $$^{99}$$Mo by the sublimation method, and its radionuclide purity was confirmed to be higher than 99.99%. The labeling efficiency of $$^{rm 99m}$$Tc-MDP was shown to be higher than 99%. These values exceed the United States Pharmacopeia requirements for a fission product, $$^{99}$$Mo. Consequently, a $$^{rm 99m}$$Tc radiopharmaceutical preparation formed by using the mentioned $$^{99}$$Mo can be a promising substitute for the fission product $$^{99}$$Mo. A longstanding problem to ensure a reliable and constant supply of $$^{99}$$Mo in Japan can be partially mitigated.



- Accesses




Category:Physics, Multidisciplinary



[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.